Position statement | Class | References |
---|---|---|
In systematic device-based, large-scale AF screening approaches for populations with unknown morbidity status, a monitoring duration of a minimum of 2 weeks of continuous monitoring is required to maximize AF detection. | 27,29,32 | |
In high-risk, highly motivated patients (e.g. after cryptogenic stroke), 1–12 months of monitoring with ILRs may be applied. | 13,31,51 |